Skip to content

Haemonetics HAE All other operating activities

All other operating activities at other companies

TFX
TeleflexTFX
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Baxter International logo
Baxter InternationalBAX
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's all other operating activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's all other operating activities?
Haemonetics (HAE) reported all other operating activities of $5.98M in Q1 2026.
How has Haemonetics's all other operating activities changed year-over-year?
Haemonetics's all other operating activities increased by 220.5% year-over-year, from $1.86M to $5.98M.
What is the long-term trend for Haemonetics's all other operating activities?
Over 3 years (2023 to 2026), Haemonetics's all other operating activities has grown at a 4.8% compound annual growth rate (CAGR), from $9.32M to $10.73M.